Skip to content

CHIRON CAPITAL MANAGEMENT, LLC: HSY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CHIRON CAPITAL MANAGEMENT, LLC on HSY, newest first. How the timeline and the estimate are built.

CHIRON CAPITAL MANAGEMENT, LLC held 3,101 HSY shares at 2025-09-30 per its 13F-HR filed 2025-11-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 3,101 shares
    Change vs previous 13F -1,200 shares

    0.5% of the 13F portfolio, value $580,042.

    13F-HR 0001830922-25-000007 filed by CHIRON CAPITAL MANAGEMENT, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2025-06-30
    13F 4,301 shares
    Change vs previous 13F -201 shares

    0.62% of the 13F portfolio, value $713,751.

    13F-HR 0001988408-25-000006 filed by CHIRON CAPITAL MANAGEMENT, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 4,502 shares
    Change vs previous 13F +2,200 shares

    0.7% of the 13F portfolio, value $769,977.

    13F-HR 0001830922-25-000003 filed by CHIRON CAPITAL MANAGEMENT, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 2,302 shares
    Change vs previous 13F +1,202 shares

    0.37% of the 13F portfolio, value $389,844.

    13F-HR 0001830922-25-000001 filed by CHIRON CAPITAL MANAGEMENT, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 1,100 shares
    Change vs previous 13F not available

    0.19% of the 13F portfolio, value $210,958.

    13F-HR 0001830922-24-000005 filed by CHIRON CAPITAL MANAGEMENT, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).